
We are pleased to announce that Stéphanie Blanc, Senior Consultant at GenSearch, will be attending the GenoTher Summit 2025, 11 June in Évry, France.
Read more “GenoTher Summit 2025: Shaping the Future of Gene Therapy”

We are pleased to announce that Stéphanie Blanc, Senior Consultant at GenSearch, will be attending the GenoTher Summit 2025, 11 June in Évry, France.
Read more “GenoTher Summit 2025: Shaping the Future of Gene Therapy”
We are pleased to announce that Sebastien Stoitzner will be attending BioEquity in Bruges 12-14 May. As a key figure in our organisation’s commitment to growth and innovation within the Life Sciences sector, Sebastien’s presence at this renowned conference underlines our dedication to staying at the forefront of industry developments.
Read more “Bio-Equity 2025”
We had the pleasure of co-hosting our #HealthTech Dinner in Basel with our partners at PwC Switzerland—an evening dedicated to exploring the evolving future of cell and gene therapies.
A heartfelt thank you to our guest speakers, Joshi Venugopal (Novartis Gene Therapies & Rare Diseases) and Gunther Busam (Orchard Therapeutics – U.S.), for their thought-provoking contributions.

Heiko Bruhn, a key figure at GenSearch, will be attending the Swiss Biotech Day 2025 in Basel, one of Europe’s leading biotechnology conferences.

Last week, the GenSearch team had the opportunity to step into the kitchen at Refugee Food Paris and assist in preparing and serving meals for the community. It was a rewarding experience that brought us together in a different way—sharing time, effort, and care for those who need it most.
Read more “Refugee Food Paris”GenSearch has signed the Charte de la Diversité, a national charter in France that encourages organisations to take practical action against discrimination and promote inclusion across all areas of employment. This commitment reflects our intention to build fairer recruitment processes and contribute to more representative leadership in the life sciences sector.
Launched in 2004, the Charte de la Diversité brings together organisations that voluntarily commit to advancing diversity in the workplace. Signatories work to ensure:
Over 5,000 companies in France have signed the Charter to date, spanning a wide range of industries and sectors.
In executive search for the life sciences industry, inclusive hiring is essential. Signing the Charte de la Diversité strengthens GenSearch’s alignment with best practices in:
Diversity in leadership leads to more robust decision-making, increased innovation, and stronger organisational performance — all critical factors in healthcare and science.
Pauline Rambaud, GenSearch has taken part in a roundtable by France Biotech entitled : Insights on the roles of CMOs, CTOs, and CSOs in innovative health companies.
Read more “Biotech Development Day – 18/11/2024”BECAUSE GREAT PROJECTS NEVER HAPPEN ALONE.
We hope you build strong alliances in 2025.